Company News
Biocon Publishes Yesafili Biosimilar Clinical Effectiveness Data
Biocon announced publication of two Phase III clinical studies in peer-reviewed journals supporting the effectiveness of its aflibercept biosimilar Yesafili™.
A 20-week extension study showed comparab
